Pneumonia News and Research

Latest Pneumonia News and Research

HHS, CCSC establish new national awards program

The US Department of Health and Human Services and the Critical Care Societies Collaborative have established a new national awards program. The National Awards Program to Recognize Achievements in Eliminating Healthcare-Associated Infections will annually recognize teams of critical care professionals and healthcare institutions that achieve excellence and notable, sustained improvements in preventing healthcare-associated infections, specifically infections in critical care.

4 Dec 2010

New national awards program to recognize healthcare institutions to eliminate HAI infection

A new national awards program will recognize teams of critical care professionals and healthcare institutions able to successfully reduce or eliminate healthcare-associated infections (HAI), a leading cause of death in the United States.

3 Dec 2010

OHA launches 2010 guidebook on leading practices in patient safety

The Ontario Hospital Association (OHA) launched the 2010 Guidebook on Leading Practices in Patient Safety entitled "Advancing Patient Safety through Ideas and Innovations", during this year's HealthAchieve.

2 Dec 2010

FDA grants 510(k) clearance to Focus Diagnostics Simplexa Flu A/B & RSV test on 3M Integrated Cycler

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.

From Quest Diagnostics 2 Dec 2010

More effective treatment for severe form of influenza

Flu season is upon us and while getting the nasty bug is bad news, the good news is it's now possible to treat the severe form of the virus more effectively, according to a Ryerson University researcher. Though Canada is not expecting a pandemic flu season this winter Health Canada reports that about 4,000 to 8,000 Canadians die each year from flu-related pneumonia.

2 Dec 2010

FDA approves CUBICIN 2-minute IV injection for MRSA skin infections, bacteremia

Cubist Pharmaceuticals, Inc. today announced that its currently-marketed antibiotic, CUBICIN (daptomycin for injection), has been approved by the U.S. Food & Drug Administration (FDA) for once-a-day dosing as a 2-minute intravenous (IV) injection.

2 Dec 2010

New experimental device could offer effective treatment option for people with swallowing disorders

In what might be one of the world's first medicinal body piercings, UC Davis Health System surgeons announced today that they have successfully implanted an experimental device in the throat of a man that will enable him to manually control his ability to swallow.

1 Dec 2010

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

NanoBio Corporation announced today that it has received a $6M grant from the Bill & Melinda Gates Foundation to support the development of a safe and effective intranasal vaccine for Respiratory Syncytial Virus (RSV).

1 Dec 2010

Gavi Alliance elects new chair to continue global immunisation efforts

Former Norwegian Minister of Health and current member of parliament Dagfinn Høybråten was unanimously elected by the GAVI Alliance Board as its new Chair, GAVI announced on the first day of its board meeting taking place in Kigali, the capital of Rwanda.

30 Nov 2010

Canadians at increased risk for flu complications not aware of all the facts

It starts with a headache, chills or that all-over-achy feeling. It comes on quickly, yet too many Canadians ignore the rapid onset of flu symptoms. But for the millions of Canadians at increased risk for developing serious complications from the flu, including people 65 and older, pregnant women and those with chronic medical conditions like chronic obstructive pulmonary disease (COPD), asthma, heart disease and diabetes, this 'laissez faire' attitude could be putting their health in jeopardy.

30 Nov 2010

GAVI says pentavalent vaccine price to fall, but $3.7B still needed to vaccinate children in developing countries

The average price of a vaccine that protects children against five diseases is expected to "drop to $2.58 next year compared to the current average price of $2.97," the GAVI Alliance said Friday, Reuters reports. The group credits the expected price decline, which "represents a decrease of 30 percent over the last seven years," in part to an "increased demand for the pentavalent, or five-in-one vaccine," according to the news service (Kelland, 11/26).

30 Nov 2010

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Merck today reported initial results from the Phase III study investigating the efficacy and safety of a treatment regimen including ISENTRESS® (raltegravir) Tablets once daily in treatment-naïve adult patients infected with HIV-1. ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve and treatment-experienced adults.

29 Nov 2010

Spectrum's FUSILEV sNDA accepted by FDA for review

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the complete response regarding its supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for Injection for treatment of patients with advanced metastatic colorectal cancer.

29 Nov 2010

QIAGEN to supply point-of-need molecular veterinary diagnostics for disease detection in emerging countries

QIAGEN has been selected to contribute to the fight against infectious diseases in animals in emerging countries by supplying an international pilot project associated with the United Nations with portable devices to perform ultra-fast molecular testing in the field.

From QIAGEN Manchester Limited 29 Nov 2010

New laboratory test for pregnant women to detect GBS infections

A more rapid laboratory test for pregnant women to detect Group B strep (GBS), the most common cause of life-threatening infections in newborns, is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth).

29 Nov 2010

Whooping cough outbreak in Oklahoma

Oklahoma is witnessing an outbreak of whooping cough with more people falling ill. Health authorities are urging all people over 7 years of age to get vaccinated against the disease.

28 Nov 2010

Phase 3 study of VEGF Trap-Eye regimen meets primary endpoint in patients with wet AMD

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every month.

22 Nov 2010

CDC data: Adults remain unvaccinated against preventable infectious illnesses

New data from the Centers for Disease Control and Prevention (CDC) show that adults remain largely unvaccinated against preventable infectious illnesses.

18 Nov 2010

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee has advised that the data presented support an indication for GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer and anal intraepithelial neoplasia (AIN) in both males and females 9 through 26 years of age.

18 Nov 2010

Statins activate bacterial-killing properties of white blood cells

Widely prescribed for their cholesterol-lowering properties, recent clinical research indicates that statins can produce a second, significant health benefit: lowering the risk of severe bacterial infections such as pneumonia and sepsis.

18 Nov 2010

Pneumonia News and Research

Latest Pneumonia News and Research

HHS, CCSC establish new national awards program

New national awards program to recognize healthcare institutions to eliminate HAI infection

OHA launches 2010 guidebook on leading practices in patient safety

FDA grants 510(k) clearance to Focus Diagnostics Simplexa Flu A/B & RSV test on 3M Integrated Cycler

More effective treatment for severe form of influenza

FDA approves CUBICIN 2-minute IV injection for MRSA skin infections, bacteremia

New experimental device could offer effective treatment option for people with swallowing disorders

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

Gavi Alliance elects new chair to continue global immunisation efforts

Canadians at increased risk for flu complications not aware of all the facts

GAVI says pentavalent vaccine price to fall, but $3.7B still needed to vaccinate children in developing countries

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Spectrum's FUSILEV sNDA accepted by FDA for review

QIAGEN to supply point-of-need molecular veterinary diagnostics for disease detection in emerging countries

New laboratory test for pregnant women to detect GBS infections

Whooping cough outbreak in Oklahoma

Phase 3 study of VEGF Trap-Eye regimen meets primary endpoint in patients with wet AMD

CDC data: Adults remain unvaccinated against preventable infectious illnesses

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Statins activate bacterial-killing properties of white blood cells

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Pneumonia News and Research

Latest Pneumonia News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in